Ruti Aga: The Six-Year Ledger — Two Years for the Drug, Four for the Paper

10 September. The least-quoted number in this case, and the one carrying the most weight. The Athletics Integrity Unit banned Ethiopian marathoner Ruti Aga for six years, effective from 10 September — the same date her provisional suspension began. The statement was issued on a Thursday; the statement does not carry a year, so I will not write one. What is on the record is this: six years.

Break six down and the arithmetic opens up. Two years for presence — a prohibited substance in the sample. Four years for tampering — the paperwork produced during the investigation was not genuine. Two plus four, six. In this case the unit of punishment is not the drug; it is the prescription pad.

The shape of the incident is plain. She won a half marathon in China in March. A sample was taken after the race. Methylprednisolone was found. A knee injury was cited. A prescription was produced — from a clinic that does not exist, signed by a family member with no medical registration, supported by a story about an 'old prescription pad' that the clinic has explicitly disowned.

I do not have the race time. I do not have splits. I do not have field quality. So I will not write a word about the performance; anything I wrote would be invention. But the arithmetic of the sanction exists, and arithmetic can be reported.

Context: what is on the record, and what is not

Ruti Aga is 32. Her record includes the 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors. Those three facts come from the AIU statement and public results archives. Her personal best is not verified in my file — external recall offers 2:18:34 from Berlin 2026 and 2:20:40 from Tokyo 2026, and both stay in brackets until I can rebuild them from an official results sheet. I do not write the number until I can rebuild the number. That habit earns its keep here.

On the record: March, China, half marathon, win. Sample after the race. Methylprednisolone. A knee-injury defence. A forged prescription. Two years for presence, four for tampering. Six years from 10 September.

Off the record: the name of the race. The time. The date the sample was collected. The year the ban expires. Whether the March result and prize money were annulled, which the statement does not say — though standard AIU practice voids the result of the competition at which the sample was collected. Whether the agent or management was investigated. Whether the Ethiopian federation said anything at all.

That list is not weak journalism. It is the honest armour of the report. When a source carries no performance data, writing a performance story is not reporting; it is composition.

The technical correction at the centre of the case

One thing needs stating plainly, because media coverage has already blurred it. Calling methylprednisolone a 'prohibited steroid' is technically wrong, and the error changes the nature of the entire case.

Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9. It is not an anabolic steroid (class S1). Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes.

The consequence is direct. A therapeutic knee injection given out of competition is entirely legal. It becomes a violation only if residue is present in an in-competition sample. A road race's testing window opens at 23:59 the day before the race, which means an injection given days earlier can be caught.

A defence existed here, and it sat in the pharmacology, not in the morality. With genuine medical records, the argument would have been that the treatment was therapeutic, that the route and timing were explicable, and that the presence charge belonged at the no-fault or no-significant-fault end — potentially a reprimand. The tampering charge cannot arise at all when the paperwork is real.

She closed that route herself. A forged document destroys the one defence that could have worked.

Core: the arithmetic, the paper, and three independent verification failures

1. What two plus four means

The AIU's structure is standard. Two years for presence is consistent with a finding on a Specified Substance where intent was not proven. Four years for tampering is the Code's standard provision.

But one thing can be read off the sum: the panel rejected the no-significant-fault mitigation. Had it been granted, the presence limb would have run shorter than two years. Serving the full two tells us the panel showed no leniency on the drug, because no defence on the drug survived to be shown leniency toward.

There is a genuine paradox here. A forged document is itself circumstantial evidence of an intent to conceal. Yet it did not escalate the presence sanction. A plausible reading is that the panel kept the two limbs separate and placed full culpability in the tampering limb. That is technically clean, and probably just. Its consequence, though, is this: the four-year limb teaches that being caught in a lie costs twice as much as being caught with the substance.

2. Three verification failures, three separate institutions

The forged paperwork can be split into a story and a pad. It failed verification in three places, and the three failures are independent of one another.

First, the clinic's existence. The issuing clinic does not exist. This is the crudest failure — the first rung of any administrative check ends there.

Second, the issuer's registration. The 'doctor' was a family member with no medical registration. Independent failure number two. Even a real clinic would not have saved this document.

Third, the 'old prescription pad' explanation. Here the case turns interesting: the defence supplied an account that the clinic then publicly disowned. The defence damaged the defence.

Three independent failures, on one document, in one window. That is not a level of carelessness. It is the signature of an operation with no verification system at all.

An athlete with robust medical support does not commission a forged prescription, because she does not need one. Real records, route and timing arithmetic, and a documented indication add up to a lawful defence. Forged paper grows in the space where all three are missing.

3. The knee: root cause, and the point where the case stops being personal

The knee-injury explanation is mechanistically credible. Intra-articular methylprednisolone for knee synovitis is ordinary sports-medicine practice in distance runners. That credibility is exactly what makes the defence legally fatal: a genuinely treated knee would have been defended with real records. The forgery rejected its own credibility.

From there the case stops being individual. The knee is a known load-bearing failure mode in marathoners. Injury puts appearance-fee income at direct risk. The cheapest, most available tool for masking pain is a glucocorticoid injection. And where the surrounding medical network is informal, the paperwork turns informal too.

The forged prescription is not the cause of the scandal. It is a symptom.

4. The party nobody charged

The four-year tampering sanction arises from an interview — from statements given under questioning, not from a document alone. That detail looks small and is not: the case was never only about catching paper. It was also about the truth of what was said.

The AIU statement names only the family member. It says nothing about whether an agent, manager or anyone else in the training group was investigated. That absence matters. Paper is not forged alone; someone commissions it, someone accepts it, someone advises producing it. Only one end of that chain is named.

I will stay careful here. 'The system failed her' is easy to say and impossible to prove, so I will not say it. I will say only that the public record contains one name, and the chain shows at least three roles.

5. China's label circuit: where the fee economy meets the testing economy

The March race is unnamed. Inference supplies one point: if the AIU took a sample there, it was a World Athletics Label-tier road race with an elite women's field and out-of-competition and in-competition testing capacity. That sits at medium-high confidence.

The economics of that tier are simple. Between Majors, these races are an attractive, low-risk income layer for East African marathoners — appearance fees, sometimes prize money, limited competitive exposure. The same tier is now the AIU's highest-yield testing ground.

The fee economy and the testing economy are colliding inside the same races, and the collision will intensify. The faster this circuit pays, the harder it will be watched.

6. What survives, and what does not

The 2026 Tokyo title and three Major second places remain the real capital of her record. The violation attaches to a March race in a later year. Absent a finding of earlier use, results before that date are not automatically annulled. The statement does not define the disqualification scope, so I will not claim the Tokyo title is tainted. I will not claim it, because the record does not say it.

What is close to certain is the March race. Standard AIU practice voids the result of the competition where the sample was collected, along with any ranking points. The statement does not spell it out. The procedure does.

7. The career arithmetic

Age 32. Six years from 10 September. A return at roughly 38. Ethiopian women's marathon depth is such that a 2:18 performer is not automatically selectable. Imagining a 38-year-old return with a doping record on file is not a training plan; it is optimism.

The ban is six years on paper and a career on the ground. Both statements are true and both belong in the same paragraph.

Contrarian: the convenient story, and what the record says

First illusion: 'six years is excessive for a glucocorticoid'

The sentence is attractive and wrong — wrong in that it answers the wrong question. Six years is not for the glucocorticoid. Two of the six are for the glucocorticoid; four are for the paper. Anyone wanting to argue disproportionality should argue it against the four-year tampering limb, not the two-year substance limb.

I will write the other side too, because it matters. If the heavy part of the sentence comes from paperwork, the question becomes: where is the consistency across tampering cases? Four years here, two there, eight somewhere else — that comparison is impossible until the full list is published. The AIU should publish it. That is my condition, registered in advance so I cannot later bend it to suit myself.

Second illusion: 'this is disproportionate enforcement against African road runners'

The correlation needs separating from the cause. It is true that East African athletes dominate AIU road-running case files. It is equally true that East African athletes dominate participation in the races being tested.

No conclusion follows from those two facts until a third number arrives: testing rate per athlete. That number is not public. Until the per-athlete testing rate is reconciled, the 'targeting' allegation is incomplete arithmetic.

One thing does follow even from incomplete arithmetic. If the real mechanism is an informal medical network and absent TUE infrastructure, the answer is not more sanction; it is medical access and education. Training groups need free, verifiable medical advice. Without it, this case will recur, and each time we will debate 'disproportionality' instead of the mechanism.

Third illusion: 'backdating gave her relief'

Counting the ban from 10 September is a procedural benefit, not a discount. Provisional suspension days credit against the total, so the real duration is unchanged. It is not the relief it looks like from outside.

Fourth — something I got wrong myself

In 2026 I spiked a colleague's story because it carried no numbers. It turned out to be the most important story of the lockdown. After that I began registering my hypotheses publicly before a tournament, so I could not retrofit a narrative afterward.

My pre-registered hypothesis for this case, written now: if the share of tampering charges in AIU's East African road-running files rises over the next twelve months, the cause will be rising document verification, not rising dishonesty. The enforcement frontier is shifting from detection to verification.

A note on timing protocol, which I will not skip

Bhubaneswar, 2026. At the Asian Championships, with no official relay splits published, I sat with a broadcast feed and a stopwatch and logged all three baton exchanges of the women's 4x400m frame by frame. That night I filed 'Baton Economics': three paragraphs, one table, zero adjectives. After that I stopped writing that a relay 'lacked coordination' and started writing which exchange cost how much.

The same discipline applies here. The AIU statement says the sample followed 'a half marathon she won in China in March.' That sentence says nothing about performance. It says a great deal about testing architecture. And when the data is empty, the emptiness is what gets written. The empty stadium made the missing data louder than the crowd.

Takeaway: where the next signal appears

Three places to watch.

First, the March race result. The AIU statement does not clarify it. If the result and prize money are voided, the message to the host circuit becomes legible.

Second, the appeal window. In principle the Court of Arbitration for Sport remains open. Document-based findings are hard to overturn, and after three independent verification failures, harder still.

Third, and most telling: the Ethiopian federation's silence. No national-level statement has surfaced. Until one does, this stays framed as one athlete's case — when it is a medical-system case.

One question stays with me. If a lawful knee injection cost only correct timing and correct paperwork, why did a 32-year-old distance runner have neither? The answer is not in her character. It is in her support structure. And until we audit that structure, we will keep arriving at the last document and stopping there.